Evidence of oxidative damage in Alzheimer's disease brain: Central role for amyloid β-peptide

Trends in Molecular Medicine

Volumn 7, Issue 12, 2001, Pages 548-554

  Butterfield, D Allan ^a   Drake, Jennifer ^a   Pocernich, Chava ^a   Castegna, Alessandra ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; ANTIOXIDANT; DNA; FREE RADICAL; LIPID; NERVE PROTEIN;

ALZHEIMER DISEASE; BIOACCUMULATION; HUMAN; LIPID PEROXIDATION; NERVE DEGENERATION; NONHUMAN; OXIDATION; OXIDATIVE STRESS; REVIEW;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; BRAIN; DNA; FREE RADICALS; HUMANS; LIPID PEROXIDATION; NERVE TISSUE PROTEINS; OXIDATIVE STRESS; RNA;

EID: 0035194145     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4914(01)02173-6     Document Type: Review

References (77)

1. Advances in Alzheimer's disease
2. Epidemiology of Alzheimer's disease
3. Amyloid β-protein and the genetics of Alzheimer's disease
4. In vivo neurotoxicity of β-amyloid [β(1-40)] and the β (25-35) fragment
5. Nerve growth factor potentiates the neurotoxicity of β amyloid
6. β-amyloid induces neuritic dystrophy in vitro: Similarities with Alzheimer pathology
7. β-amyloid-associated free radical oxidative stress and neurotoxicity: Implications for Alzheimer's disease
8. Review: Alzheimer's amyloid β-peptide-associated free radical oxidative stress and neurotoxicity
9. Oxidative stress hypothesis in Alzheimer disease
10. Impairment of membrane transport and signal transduction systems by amyloidogenic proteins
11. Role of spermine in amyloid β-peptide-associated free radical-induced neurotoxicity
12. The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: The role of Aβ1-42
13. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
14. Neuroinflammatory signaling upregulation in Alzheimer's disease
15. Protein oxidation processes in aging brain
16. Apolipoprotein E modulates Alzheimer's Aβ(1-42)-induced oxidative damage to synaptosomes in an allele-specific manner
17. Evidence for a membrane defect in Alzhemier disease brain
18. Regional membrane phospholipid alterations in Alzheimer's disease
19. Vitamin E protects against amyloid peptide (25-35)-induced changes in neocortical synaptosomal membrane lipid structure and composition
20. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde, and related aldehydes
21. 4-Hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease
22. 4-Hydroxynonenal-derived advanced lipid peroxidation products are increased in Alzheimer's disease
23. 4-Hydroxy-2-nonenal pyrrole adducts in human neurodegenerative disease
24. The lipid peroxidation product, 4-hydroxy-2-transnonenal, alters the conformation of cortical synaptosomal membrane proteins
25. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid β-peptide
26. 4-Hydroxynonenal, a product of lipid peroxidation, damages cholinergic neurons and impairs visuospatial memory in rats
27. Glutathione elevation and its protective role in acrolein-induced protein damage in synaptosomal membranes: Relevance to brain lipid peroxidation in neurodegenerative disease
28. Protein-bound acrolein: A novel marker of oxidative stress in Alzheimer's disease
29. Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures
30. Peroxynitrite-induced alterations in synaptosomal membrane proteins: Insight into oxidative stress in Alzheimer's disease
31. Decreased glutathione transferase in brain and ventricular fluid in Alzheimer's disease
32. Formation of isoprostanes-like compounds (neuroprostanes) in vivo from docosahaexanoic acid
33. Cerebrospinal fluid F2 isoprostane levels are increased in Alzheimer's disease
34. Characterization of 8-epiprostaglandin F2α as a marker of amyloid β-peptide-induced oxidative damage
35. The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients
36. Brain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease
37. β-amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: Implications to Alzheimer's disease
38. Protein oxidation and aging
39. Free radical oxidation of brain proteins in accelerated senescence and its modulation by N-tert-butyl-phenylnitrone
40. Biochemistry and pathology of radical-mediated protein oxidation
41. Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins
42. Amyloid β-peptide-associated free radical oxidative stress, neurotoxicity and Alzheimer's disease
43. Oxidation of cytosolic proteins and expression of creatine kinase BB in frontal lobe in different neurodegenerative disorders
44. An assessment of oxidative damage to proteins, lipids, and DNA in brains from patients with Alzheimer's disease
45. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation
46. Protein oxidation in the brain in Alzheimer's disease
47. Oxidative damage in Alzheimer's
48. Oxidative modification of creatine kinase BB in Alzheimer's disease brain
49. Oxidatively induced structural alteration of glutamine synthetase assessed by analysis of spin label incorporation kinetics: Relevance to Alzheimer's disease
50. Oxidative modification of glutamine synthetase by amyloid β-peptide
51. Oxidative chemistry of peroxynitrite
52. Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer's brain indicates region-specific accumulation
53. Widespread peroxynitrite-mediated damage in Alzheimer's disease
54. Decreased thioredoxin and increased thioredoxin reductase levels in Alzheimer's disease brain
55. Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype
56. Vulnerability of synaptosomes from ApoE knock-out mice to structural and oxidative modifications induced by Aβ(1-40): Implications for Alzheimer's disease
57. Methionine residues as endogenous antioxidants in proteins
58. Decrease in peptide methionine sulfoxide reductase in Alzheimer's disease brain
59. In vitro and in vivo oxidative stress associated with Alzheimer's amyloid β-peptide (1-42)
60. Vitamin E prevents Alzheimer's amyloid β-peptide (1-42)-induced protein oxidation and reactive oxygen species formation
61. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease
62. Increased nuclear DNA oxidation in the brain in Alzheimer's disease
63. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease
64. Mitochondrial DNA damage as a mechanism of cell loss in Alzheimer's disease
65. Mitochondrial abnormalities in Alzheimer's disease
66. Ratio of 8-hydroxyguanine in intact DNA to free 8-hydroxyguanine is increased in Alzheimer disease ventricular cerebrospinal fluid
67. Increased levels of DNA breaks in cerebral cortex of Alzheimer's disease patients
68. Neuronal DNA damage precedes tangle formation and is associated with up-regulation of nitrotyrosine in Alzheimer's disease brain
69. Decreased base excision repair and increased helicase activity in Alzheimer's disease brain
70. Increased poly(ADP-ribosyl)ation of nuclear proteins in Alzheimer's disease
71. Fibrillar Alzheimer's amyloid peptide Aβ(1-42) stimulates low density lipoprotein binding and cell association, free radical production and cell cytotoxicity in PC12 cells
72. The mechanism of oxidative stress and neurotoxicity of Alzheimer's Aβ(1-42) is different than that of Aβ(25-35)
73. Perturbed endoplasmic reticulum function, synaptic apoptosis and the pathogenesis of Alzheimer's disease
74. Alzheimer's disease amyloid-β binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits
75. NeurotoxicAβ peptides increase oxidative stress in vivo through NMDA-receptor and nitric-oxide-synthase mechanisms, and inhibit complex IV activity and induce a mitochondrial permeability transition in vitro
76. Fibrillar β-amyloid evokes oxidative damage in a transgenic mouse model of Alzheimer's disease
77. Brain oxidative stress in animal models of accelerated aging and the age-related neurodegenerative disorders, Alzheimer's disease and Huntington's disease